Open Access

[Corrigendum] miR-30d inhibits cell biological progression of Ewing’s sarcoma by suppressing the MEK/ERK and PI3K/Akt pathways in vitro

  • Authors:
    • Conglin Ye
    • Xiaolong Yu
    • Xuqiang Liu
    • Min Dai
    • Bin Zhang
  • View Affiliations

  • Published online on: December 18, 2020     https://doi.org/10.3892/ol.2020.12394
  • Article Number: 133
  • Copyright : © Ye et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

February-2021
Volume 21 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ye C, Yu X, Liu X, Dai M and Zhang B: [Corrigendum] miR-30d inhibits cell biological progression of Ewing’s sarcoma by suppressing the MEK/ERK and PI3K/Akt pathways <em>in vitro</em>. Oncol Lett 21: 133, 2021
APA
Ye, C., Yu, X., Liu, X., Dai, M., & Zhang, B. (2021). [Corrigendum] miR-30d inhibits cell biological progression of Ewing’s sarcoma by suppressing the MEK/ERK and PI3K/Akt pathways <em>in vitro</em>. Oncology Letters, 21, 133. https://doi.org/10.3892/ol.2020.12394
MLA
Ye, C., Yu, X., Liu, X., Dai, M., Zhang, B."[Corrigendum] miR-30d inhibits cell biological progression of Ewing’s sarcoma by suppressing the MEK/ERK and PI3K/Akt pathways <em>in vitro</em>". Oncology Letters 21.2 (2021): 133.
Chicago
Ye, C., Yu, X., Liu, X., Dai, M., Zhang, B."[Corrigendum] miR-30d inhibits cell biological progression of Ewing’s sarcoma by suppressing the MEK/ERK and PI3K/Akt pathways <em>in vitro</em>". Oncology Letters 21, no. 2 (2021): 133. https://doi.org/10.3892/ol.2020.12394